0000950170-23-059580.txt : 20231106
0000950170-23-059580.hdr.sgml : 20231106
20231106180005
ACCESSION NUMBER: 0000950170-23-059580
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231103
FILED AS OF DATE: 20231106
DATE AS OF CHANGE: 20231106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mainolfi Nello
CENTRAL INDEX KEY: 0001821189
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39460
FILM NUMBER: 231380994
MAIL ADDRESS:
STREET 1: C/O KYMERA THERAPEUTICS, INC.
STREET 2: 200 ARSENAL YARDS, SUITE 230
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kymera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001815442
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 812992166
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 ARSENAL YARDS BLVD., SUITE 230
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 857-285-5314
MAIL ADDRESS:
STREET 1: 200 ARSENAL YARDS BLVD., SUITE 230
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
ownership.xml
4
X0508
4
2023-11-03
0001815442
Kymera Therapeutics, Inc.
KYMR
0001821189
Mainolfi Nello
C/O KYMERA THERAPEUTICS, INC.
200 ARSENAL YARDS BLVD., SUITE 230
WATERTOWN
MA
02472
true
true
false
false
Chief Executive Officer
false
Common Stock
2023-11-03
4
M
false
2368
2.08
A
588938
D
Common Stock
2023-11-03
4
M
false
17632
2.08
A
606570
D
Stock Option (Right to Buy)
2.08
2023-11-03
4
M
false
2368
0.00
D
2029-05-22
Common Stock
2368
0
D
Stock Option (Right to Buy)
2.08
2023-11-03
4
M
false
17632
0.00
D
2029-11-13
Common Stock
17632
528972
D
The shares underlying this stock option vest in forty-eight (48) equal monthly installments following the vesting commencement date of February 7, 2019, subject to the reporting person's continued employment through each vesting date.
The shares underlying this stock option vest in forty-eight (48) equal monthly installments following the vesting commencement date of November 14, 2019, subject to the reporting person's continued employment through each vesting date.
/s/ Bruce N. Jacobs, as Attorney-in-Fact
2023-11-06